Median anti-malarial antibody levels and total IgE levels (Q1-Q3) (International Units per microlitre except IgE levels measured in ng/mL) | |||||||
---|---|---|---|---|---|---|---|
Anti-AMA1_Pf | Anti-MSP1_Pf | Anti-MSP2_Pf | Anti-NANP_Pf | Total IgE | Anti- AMA1_Pv | Anti- MSP1_Pv | |
A (n = 532) | 531.05 | 1450.15 | 1126.80 | 3390.35 | 4390.40 | 3356.15 | 2190.60 |
(211.96-1587.54) | (589.35-3092.42) | (516.52-2893.34) | (1878.68-6233.46) | (1850.20-8572.42) | (1407.27-9834.10) | (1113.22-5902.23) | |
B (n = 186) | 885.10 | 1619.40 | 1492.45 | 4460.45 | 4163.30 | 3662.70 | 3559.70 |
(255.78-1972.92) | (603.70-3420.35) | (637.78-4450.73) | (2344.25-8624.20) | (1467.97-8258.32) | (1559.33-9297.81) | (1332.49-8794.58) | |
p value | 0.004* | 0.239 | 0.027* | 0.002* | 0.405 | 0.405 | 0.003* |
Male (n = 353) (range) | 592.43 | 1597.69 | 1340.89 | 3479.23 | 5719.66 | 3166.38 | 2386.78 |
(242.19-1701.04) | (673.87-3395.07) | (561.36-3324.04) | (2010.22-6952.50) | (2569.56-10853.45) | (1403.19-9701-93) | (1238.26-6724.18) | |
Female (n = 365) (range) | 624.68 | 1501.08 | 1214.67 | 3585.46 | 3298.72 | 3691.38 | 2326.02 |
(200.56-1958.36) | (587.94-3349.18) | (519.17-3369.79) | (1913.57-6683.77) | (1189.41-5921.31) | (1591.25-10161.87) | (1122.44-6756.56) | |
p value | 0.791 | 0.493 | 0.865 | 0.476 | <0.001* | 0.056 | 0.983 |